Director
DIN: 06943062
Rajendra Prasad Bhalotia is currently associated with 2 companies in various capacities such as Designated Partner, Director and Individual Promoter. They serve as a Director at KANAV TECHNOLOGY CONSULTANTS LLP and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 06943062.Rajendra Prasad Bhalotia is currently involved in 3 different roles. Their most recent position is with MILLIONEYES HEALTHCARE TECHNOLOGIES PRIVATE LIMITED as a Director. The first company Rajendra Prasad Bhalotia was appointed to as a director was KANAV TECHNOLOGY CONSULTANTS LLP. Rajendra Prasad Bhalotia is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
Rajendra Prasad Bhalotia is currently associated with 2 companies in various capacities such as Designated Partner, Director and Individual Promoter. They serve as a Director at KANAV TECHNOLOGY CONSULTANTS LLP and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 06943062.Rajendra Prasad Bhalotia is currently involved in 3 different roles. Their most recent position is with MILLIONEYES HEALTHCARE TECHNOLOGIES PRIVATE LIMITED as a Director. The first company Rajendra Prasad Bhalotia was appointed to as a director was KANAV TECHNOLOGY CONSULTANTS LLP. Rajendra Prasad Bhalotia is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
3
Male
India
Call +91 81049 46419 and we'll pull the verified contact details for you.
Current Companies (1)
Current LLPs (1)
Past Companies (0)
2y 5m 1y 3m Interval
| Company Name | Designation | Date of Appointment |
|---|---|---|
| MILLIONEYES HEALTHCARE TECHNOLOGIES PRIVATE LIMITED | Director | 29-Sep-2018 |
| MILLIONEYES HEALTHCARE TECHNOLOGIES PRIVATE LIMITED | Individual Promoter | 29-Sep-2018 |